Today: 8 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

U.S. natural gas futures fell about 4% early Wednesday to $3.81/mmBtu after a recent surge on colder forecasts and record LNG export demand. EQT Corp shares slipped 0.5% in extended trading, last quoted at $54.36. Average gas flows to U.S. LNG export plants hit 18.5 bcfd so far in December, topping November’s record, LSEG data showed. Investors are watching winter forecasts and upcoming February earnings reports.
31 December 2025
···
XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP traded near $1.87 early Wednesday, up 0.5%, as U.S. spot XRP ETFs logged a 29th straight session of net inflows, totaling $1.15 billion since launch. Bitcoin and ether also rose, while XRP funds drew money even as bitcoin and ether funds saw outflows in December. The 21Shares XRP ETF registration became effective Dec. 10, SEC filings showed. Traders are watching the $2 resistance level amid thin holiday liquidity.
31 December 2025
·
Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

The Dow closed down 94.87 points, or 0.20%, at 48,367.06 in thin holiday trading Tuesday. Federal Reserve minutes showed policymakers split after a quarter-point rate cut, keeping attention on the 2026 rate outlook. Boeing secured an $8.6 billion Pentagon contract tied to the F-15 Israel Program. U.S. bond markets will close early at 2 p.m. ET Wednesday; stocks are shut Thursday for New Year’s Day.
31 December 2025
·······
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

Scholar Rock shares fell 3.2% to $43.76 Tuesday afternoon, underperforming biotech peers as investors watched for updates on FDA reinspection timing for its lead drug, apitegromab. The company aims to resubmit its biologics license application in 2026 after the Indiana fill-finish site, now owned by Novo Nordisk, completes remediation and is reinspected by year-end 2025.
30 December 2025
·
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL shares dropped 3.3% to $84.95 Tuesday afternoon, extending a two-day slide. An Oregon Health & Science University release highlighted PATHFINDER 2 data and confirmed a first-quarter 2026 FDA submission for Galleri. Investors await management’s Jan. 12 update at the J.P. Morgan Healthcare Conference. The stock is down 7.2% since Friday’s close.
30 December 2025
··
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions shares dropped 3.5% to $10.02 in thin year-end trading Tuesday, underperforming a steady U.S. market. The decline followed Federal Reserve minutes showing policy divisions and came as investors awaited January jobs and inflation data. Trading volume in TIC lagged its recent average, and peers Mistras Group and Jacobs Solutions slipped less than 1%.
30 December 2025
··
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Travere Therapeutics shares fell 3.8% to $37.39 Tuesday afternoon, outpacing declines in biotech ETFs. SEC filings showed Chief Medical Officer Jula Inrig and Chief Commercial Officer Pieter Heerma sold shares on Dec. 24 under pre-arranged 10b5-1 plans. The moves come weeks before a key FDA decision on Filspari for FSGS, set for Jan. 13, 2026. Trading volume reached about 893,000 shares.
30 December 2025
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals shares fell 3% to $23.33 in thin afternoon trading Tuesday, extending a two-day slide and leaving the stock about 12% below its June high. Biotech ETFs underperformed the broader market, with the iShares Nasdaq Biotechnology ETF down 1.2%. Investors are awaiting the Federal Reserve’s meeting minutes and Catalyst’s next update in January.
30 December 2025
··
Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics shares fell 3% to $77.94 Tuesday afternoon, underperforming a 1.4% drop in the SPDR S&P Biotech ETF. The decline follows December’s $692 million equity raise and positive Phase 1b data for its STAT6 degrader KT-621. The stock traded about 9% below its recent $86 offering price. Investors are watching for updates on trial progress and cash burn ahead of 2026 milestones.
30 December 2025
··
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries shares fell 3.9% to $8.90 Tuesday after early gains, trading between $8.90 and $9.39. The drop followed news that CEO Lewis Black met U.S. officials and signed a deal tied to future tungsten supply from the Sangdong mine in South Korea, which is set to start production in early 2026. Almonty recently raised $129.4 million in a U.S. share sale and delivered its first ore to Sangdong’s staging area.
30 December 2025
···
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Praxis Precision Medicines shares fell 3% to $295.50 Tuesday afternoon, retreating after a 14% surge Monday on FDA Breakthrough Therapy Designation for ulixacaltamide in essential tremor. The company plans to submit a New Drug Application in early 2026. Jefferies and BTIG raised price targets following the FDA news.
30 December 2025
··
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Caris Life Sciences shares fell 1.8% to $27.44 by 2:41 p.m. ET Tuesday, underperforming biotech peers as sector benchmarks declined. The drop followed recent attention on Caris’ Genentech partnership, which includes $25 million upfront and up to $1.1 billion in potential milestones. The S&P 500 and Nasdaq were flat. Investors are watching Caris’ test volumes and revenue guidance.
30 December 2025
1 … 340 341 342 343 344 … 588

Stock Market Today

  • Factorial Energy's $1.3 Billion Nasdaq Debut Accelerates Solid-State Battery Commercialization
    June 8, 2026, 3:23 PM EDT. Factorial Energy, a U.S. solid-state battery developer, has listed on Nasdaq (tickers FAC, FACWW) on June 8, 2026, following a business combination with Cartesian Growth Corporation III, valuing the company at approximately $1.3 billion. The transaction brought in over $100 million in gross proceeds to fund commercialization efforts across defense, aerospace, hyperscale data centers, drones, robotics, and e-mobility sectors. Factorial's partnerships with drone integrators KULR, Tulip Tech, and JRES span three continents. The firm is spearheading the first U.S. solid-state battery production program for passenger vehicles with Karma Automotive. A significant milestone includes a Mercedes-Benz EQS test vehicle completing a 1,205 km trip on a single FEST cell charge, showcasing the potential for enhanced battery performance.

Latest articles

Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

8 June 2026
Archer Aviation shares jumped 4.2% to $5.77 after last week’s 13.2% drop, as investors rotated back into growth and air-taxi stocks; the move follows Archer’s milestone as the first eVTOL developer to close Phase 3 of FAA certification, but heavy losses and high cash burn keep the stock highly sensitive to regulatory and financial risks.
Galaxy Digital spikes 24% as investors look at AI data center plans

Galaxy Digital spikes 24% as investors look at AI data center plans

8 June 2026
Galaxy Digital shares soared 23.6% to $31.07 after CEO Mike Novogratz said its West Texas AI data center—half of which is already leased—now represents more than half the company’s value, shifting focus from crypto to AI infrastructure; the stock’s surge outpaced bitcoin’s 2.7% rise as investors repriced Galaxy’s data-center business amid execution risks and strong analyst buy ratings.
Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

Nu Shares Drop, $1 Billion Buyback Doesn’t Ease Market

8 June 2026
Nu Holdings shares slid 3.1% to $11.60 as investors weighed CFO transition risks and rising credit costs, erasing last week’s 4.1% buyback-driven bounce; BofA downgraded the stock to Underperform with a $10 target, citing uncertainty from Lago’s exit, while Nu’s $1B buyback failed to stem a 10.7% weekly drop and 30.7% year-to-date decline, leaving shares just above their 52-week low.
Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

Inno Holdings Soared Nearly 20 Times—AI Deal Includes a Caveat

8 June 2026
Inno Holdings shares soared twentyfold to $20.97 after announcing a $3 million AI sales agent deal for its used mobile phone business, but investor risks remain with a recent $60 million at-the-market stock program and ongoing going-concern warnings in filings, as the project is still in early development and not yet commercially launched.
Go toTop